financetom
Business
financetom
/
Business
/
US FDA issues warning letters to retailers against underage sale of ZYN nicotine pouches
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA issues warning letters to retailers against underage sale of ZYN nicotine pouches
Apr 4, 2024 3:19 PM

April 4 (Reuters) - The U.S. Food and Drug

Administration on Thursday said it had issued warning letters

and filed civil money penalty complaints against retailers

engaged in underage sale of various flavors of ZYN nicotine

pouches.

The FDA said it had issued 119 warning letters to

brick-and-mortar retailers and had filed 41 civil money penalty

complaints seeking more than $55,000 in total for underage sales

of flavored ZYN nicotine pouches, including espressino, black

cherry, lemon spritz, and cucumber lime.

ZYN nicotine pouches are manufactured by Swedish Match,

which is owned by Marlboro maker Philip Morris International ( PM )

. PMI claims that the pouches do not contain tobacco and

are inherently smoke-free.

PMI did not immediately respond for a request for comment.

The FDA said it was illegal for any retailer to sell any

tobacco product - including cigarettes, e-cigarettes, cigars,

and nicotine pouches - to anyone under the age of 21. The agency

added that nicotine pouches were a type of tobacco product.

"There is no excuse for selling tobacco products to any

underage person, and FDA will hold retailers accountable for

those violations-especially those who continue to do so after

being warned," said Brian King, director of the FDA's Center for

Tobacco Products.

New tobacco products to be legally marketed in the United

States must receive an authorization, the FDA said, adding that

to date, it had authorized only four oral tobacco products.

As of April, the FDA had not authorized any ZYN product for

sale in the United States, it said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Canada's K92 Mining halts some operations at Papua New Guinea mine after worker death
Canada's K92 Mining halts some operations at Papua New Guinea mine after worker death
Mar 19, 2024
March 19 (Reuters) - Canada's K92 Mining ( KNTNF ) said on Tuesday underground operations at the Kainantu Gold Mine in Papua New Guinea have been temporarily suspended after a non-industrial incident earlier this month led to the death of an employee. The Canadian miner, however, said processing operations, which had been suspended following the incident on March 10, have...
Cardlytics Insider Bought Shares Worth $8,963,859, According to a Recent SEC Filing
Cardlytics Insider Bought Shares Worth $8,963,859, According to a Recent SEC Filing
Mar 19, 2024
08:53 AM EDT, 03/19/2024 (MT Newswires) -- Clifford Sosin, 10% Owner, around March 15, 2024, executed a purchase for 661,715 shares in Cardlytics ( CDLX ) for $8,963,859. Following the Form 4 filing with the SEC, Sosin has control over a total of 6,023,676 shares of the company, with 6,023,676 shares controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1666071/000119380524000390/xslF345X03/e619381_4-cdlx.xml Price: 13.25, Change: +0.19,...
Apollo Silver Secures 2024 Drill Permit for Waterloo Property
Apollo Silver Secures 2024 Drill Permit for Waterloo Property
Mar 19, 2024
08:54 AM EDT, 03/19/2024 (MT Newswires) -- Apollo Silver Corp. ( APGOF ) , which rose by more than 10% yesterday, said Tuesday that it has secured a conditional temporary use permit from the County of San Bernardino. The permit authorizes 2024 drilling activities at the Waterloo Silver-Barite Property. Results from the 2024 assay testing program have been received and...
Harmony Biosciences Holdings Insider Sold Shares Worth $383,328, According to a Recent SEC Filing
Harmony Biosciences Holdings Insider Sold Shares Worth $383,328, According to a Recent SEC Filing
Mar 19, 2024
08:56 AM EDT, 03/19/2024 (MT Newswires) -- Jeffrey Dierks, CHIEF COMMERCIAL OFFICER, on March 15, 2024, sold 11,979 shares in Harmony Biosciences Holdings ( HRMY ) for $383,328. SEC Filing: https://www.sec.gov/Archives/edgar/data/1802665/000141588924008350/xslF345X03/form4-03182024_110312.xml Price: 32.31, Change: +0.72, Percent Change: +2.28 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved